The Use of PRF in the Management of Soft Tissue Healing
PRF
The Use of Platelet-rich Fibrin in the Management of Soft Tissue Healing and Pain in Post-extraction Sockets: a Randomized Clinical Trial
1 other identifier
interventional
32
1 country
1
Brief Summary
The present study aimed to evaluate the clinical effect of platelet-rich fibrin to improve epithelialization and decrease postoperative pain in post extraction sockets
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedFirst Submitted
Initial submission to the registry
December 17, 2019
CompletedFirst Posted
Study publicly available on registry
December 30, 2019
CompletedDecember 30, 2019
December 1, 2019
2.3 years
December 17, 2019
December 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the soft tissue epithelialization speed in post-extraction sockets
One and two weeks after extraction, an assessment of soft tissue healing around the sockets was performed using the healing index system described by Landry et al. The following parameters were used to assess the level of healing: colour of tissues; epithelialisation of wound margins; presence of bleeding on palpation; granulation; and suppuration. The level of healing was scored as very poor, poor, good, very good, or excellent.
90 days
Secondary Outcomes (2)
Postoperative pain
90 days
Number of consumed analgesic
90 days
Study Arms (2)
Test group
EXPERIMENTALPost-extraction sockets covered with Platelet-Rich Fibrin membrane (n=16)
Control Goroup
NO INTERVENTIONPost-extraction sockets left to spontaneous healing/clot and primary closure (n=16).
Interventions
The sockets of the test group will be filled with two platelet-rich fibrin membranes followed by suture
Eligibility Criteria
You may qualify if:
- Participants ≥ 18 years of age;
- Participants needing molar extraction in the mandible or maxilla region.
You may not qualify if:
- Smokers;
- Pregnant;
- Participants with motor difficulties that impeded or hampered hygien;
- Participants with decompensated metabolic diseases;
- Participants with periodontal disease;
- Participants with history of radiotherapy or use of bisphosphonates.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dental Clinical Research Center of the Fluminense Federal University
Niterói, Rio de Janeiro, 24020-140, Brazil
Related Publications (3)
Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L. Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2020 Apr;91(4):462-472. doi: 10.1002/JPER.19-0290. Epub 2019 Nov 17.
PMID: 31471902BACKGROUNDCastro AB, Cortellini S, Temmerman A, Li X, Pinto N, Teughels W, Quirynen M. Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure. Int J Oral Maxillofac Implants. 2019 July/August;34(4):855-864. doi: 10.11607/jomi.7275. Epub 2019 Feb 11.
PMID: 30742137BACKGROUNDDohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009. Epub 2006 Jan 10.
PMID: 16504850RESULT
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Vittorio Moraschini, PhD
Fluminense Federal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 17, 2019
First Posted
December 30, 2019
Study Start
April 15, 2017
Primary Completion
August 15, 2019
Study Completion
November 15, 2019
Last Updated
December 30, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share